MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology

Anaplastic thyroid cancer (ATC) is among the most lethal types of cancers, characterized as a fast-growing and highly invasive thyroid tumor that is unresponsive to surgery and radioiodine, blunting therapeutic efficacy. Classically, genetic alterations in tumor suppressor TP53 are frequent, and cum...

Full description

Saved in:
Bibliographic Details
Main Authors: Cesar Seigi Fuziwara, Edna Teruko Kimura
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2014/743450
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554709190180864
author Cesar Seigi Fuziwara
Edna Teruko Kimura
author_facet Cesar Seigi Fuziwara
Edna Teruko Kimura
author_sort Cesar Seigi Fuziwara
collection DOAJ
description Anaplastic thyroid cancer (ATC) is among the most lethal types of cancers, characterized as a fast-growing and highly invasive thyroid tumor that is unresponsive to surgery and radioiodine, blunting therapeutic efficacy. Classically, genetic alterations in tumor suppressor TP53 are frequent, and cumulative alterations in different signaling pathways, such as MAPK and PI3K, are detected in ATC. Recently, deregulation in microRNAs (miRNAs), a class of small endogenous RNAs that regulate protein expression, has been implicated in tumorigenesis and cancer progression. Deregulation of miRNA expression is detected in thyroid cancer. Upregulation of miRNAs, such as miR-146b, miR-221, and miR-222, is observed in ATC and also in differentiated thyroid cancer (papillary and follicular), indicating that these miRNAs’ overexpression is essential in maintaining tumorigenesis. However, specific miRNAs are downregulated in ATC, such as those of the miR-200 and miR-30 families, which are important negative regulators of cell migration, invasion, and epithelial-to-mesenchymal transition (EMT), processes that are overactivated in ATC. Therefore, molecular interference to restore the expression of tumor suppressor miRNAs, or to blunt overexpressed oncogenic miRNAs, is a promising therapeutic approach to ameliorate the treatment of ATC. In this review, we will explore the importance of miRNA deregulation for ATC cell biology.
format Article
id doaj-art-6656cc98c8b44d4683fc825d4be9d007
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-6656cc98c8b44d4683fc825d4be9d0072025-02-03T05:50:43ZengWileyInternational Journal of Endocrinology1687-83371687-83452014-01-01201410.1155/2014/743450743450MicroRNA Deregulation in Anaplastic Thyroid Cancer BiologyCesar Seigi Fuziwara0Edna Teruko Kimura1Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Avenida Professor Lineu Prestes 1524, Room 414, CEP, Butantã, 05508-000 São Paulo, SP, BrazilDepartment of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Avenida Professor Lineu Prestes 1524, Room 414, CEP, Butantã, 05508-000 São Paulo, SP, BrazilAnaplastic thyroid cancer (ATC) is among the most lethal types of cancers, characterized as a fast-growing and highly invasive thyroid tumor that is unresponsive to surgery and radioiodine, blunting therapeutic efficacy. Classically, genetic alterations in tumor suppressor TP53 are frequent, and cumulative alterations in different signaling pathways, such as MAPK and PI3K, are detected in ATC. Recently, deregulation in microRNAs (miRNAs), a class of small endogenous RNAs that regulate protein expression, has been implicated in tumorigenesis and cancer progression. Deregulation of miRNA expression is detected in thyroid cancer. Upregulation of miRNAs, such as miR-146b, miR-221, and miR-222, is observed in ATC and also in differentiated thyroid cancer (papillary and follicular), indicating that these miRNAs’ overexpression is essential in maintaining tumorigenesis. However, specific miRNAs are downregulated in ATC, such as those of the miR-200 and miR-30 families, which are important negative regulators of cell migration, invasion, and epithelial-to-mesenchymal transition (EMT), processes that are overactivated in ATC. Therefore, molecular interference to restore the expression of tumor suppressor miRNAs, or to blunt overexpressed oncogenic miRNAs, is a promising therapeutic approach to ameliorate the treatment of ATC. In this review, we will explore the importance of miRNA deregulation for ATC cell biology.http://dx.doi.org/10.1155/2014/743450
spellingShingle Cesar Seigi Fuziwara
Edna Teruko Kimura
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
International Journal of Endocrinology
title MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
title_full MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
title_fullStr MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
title_full_unstemmed MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
title_short MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
title_sort microrna deregulation in anaplastic thyroid cancer biology
url http://dx.doi.org/10.1155/2014/743450
work_keys_str_mv AT cesarseigifuziwara micrornaderegulationinanaplasticthyroidcancerbiology
AT ednaterukokimura micrornaderegulationinanaplasticthyroidcancerbiology